This week, the Puget Sound Business Journal tapped Carla Greenbaum, MD for this year’s Lifetime Achievement Award, recognizing her decades-long dedication to type 1 diabetes (T1D) research. Dr. Greenbaum’s name has become tantamount to diabetes expertise in the community, and her relentless pursuit of progress throughout her career has changed the landscape of T1D treatment – driving changes that have substantially enhanced the diagnosis, management, and overall quality of life for individuals living with T1D.
Dr. Greenbaum joined the Benaroya Research Institute (BRI) in 2000 and is now the Director of the Institute’s Center for Interventional Immunology. At BRI, Greenbaum’s forward-thinking and innovation have piloted multi-decade, longitudinal clinical studies to understand T1D disease development and progression. She envisioned and then built a team positioned to conduct high quality, high impact clinical research, and established a highly collaborative culture aiming to accelerate translating science to health.